Presented by Tim Weller
For the third week in a row, the big picture has continued to improve. New cases, positive testing rates, and hospitalizations are trending down, while vaccinations are scaling up. If these trends continue, we are likely through the worst of the pandemic and should see continued improvement ahead.
While the trends are positive, the remaining significant risk is that a more contagious variant of the virus could accelerate infection growth, as it has in other countries. Offsetting that risk will be the progress in vaccinations. We are now at more than 13 percent of the population having had at least their first shot, up from 10 percent last week. While the risk of a new variant is real, as of right now, we do appear to be through the worst of it, and there is a real possibility of continued rapid improvement.
The economic news is starting to improve as well, although there are still signs of weakness. The federal stimulus bill has improved both confidence and spending, and medical improvements are allowing reopenings in many states. Job growth in January was positive, up from a decline in December, although it remains low. Plus, layoffs are still below the recent highs. Between the medical improvements and the federal stimulus program, the economy is likely past the worst of the pandemic damage.
Overall, while the current headlines continue to be bad and real risks remain, there are signs of improvement and reasons to believe we may be past the worst of it. That continues to be what markets are thinking, as they have hit more all-time highs despite some turbulence. Let’s take a look at the details.
The Virus: Case Growth Continues to Decline
New cases per day. The most obvious metric for tracking the virus is daily new cases. After holiday surges, we have now seen case growth drop back to levels last seen in November before Thanksgiving. The trend continues to be downward, although there is still a risk that a more infectious variant of the virus could push infection rates up again, as seen in other countries. While we need to keep an eye on that risk, so far at least the trend remains positive. Absent that risk, it looks like we are past the crest of the third wave.
Looking at the numbers, the improvement is clear. New daily infection rates were 96,806 on February 10, down from 114,463 a week earlier. The seven-day average number of new cases per day was 105,798, down from 136,383 a week ago. While case growth remains too high, the good news is that it is down significantly, and the trend continues to be downward. If this trend holds, we are now past the peak of the third wave.
Hospitalizations. We also see the same trend with hospitalizations, which is even more encouraging. While case reporting has weaknesses in how the data is reported, hospitalizations are much better as a real-time indicator. Here, too, we can see a peak and decline. On February 10, there were 76,979 people hospitalized, down from 91,440 a week earlier. As a coincident indicator and as a better indicator of the stress on the health care system, this supports the idea that the trend has turned.
Testing news. The news on testing, however, is more mixed. While the positive rate continues to decline, we have also seen a decline in overall testing numbers. Daily testing remains at historically high levels, but the decline is potentially a risk factor. Nonetheless, the continued decline in the positive testing rates is more supporting evidence for the change in trend and could be a leading indicator of further improvements.
Source: Johns Hopkins University
Vaccinations. Finally, we are now well into the vaccination process. More than 13 percent of the U.S. population has now had at least the first shot of the vaccine, up from 10 percent last week. This has very likely contributed to the positive change in trend in the other data series. Vaccinations are also likely to accelerate in the coming weeks, which should drive further improvements.
The major risks right now are, first, that the Super Bowl and associated events could have started another round of infections. We have not seen that yet, but we will need to watch out for that over the next couple of weeks. The second is that a more contagious strain of the virus could take root and accelerate infections again. Here, too, we see no immediate signs of this, but evidence of these strains has now been reported in 35 states. So far, there has been limited spread, but this remains a very real risk.
The bottom line is that while infection growth is still too high, the data suggests that we are through the worst of it. Absent Super Bowl cases or further spread of the more infectious strains of the virus, we are therefore likely to see more improvement in the next couple of weeks. As vaccine deployment accelerates, the downside risks will drop quickly. While the risks are real, so is the progress.
The Economy: Damage Is Moderating
Jobs and consumers. While the backward-looking economic data remains soft, we are seeing improvement in more current indicators as a combination of medical improvement, slow reopening, and the federal stimulus helps employment and confidence. Job growth went positive again in January, after declines in December, and layoffs have stayed near recent lows. Confidence also seems to have bottomed. Further, while the data is preliminary, the combination of a firming job market and stabilizing confidence appears to have started to increase consumer spending. With all of this, the data is showing we are likely through the worst of the economic impact of the pandemic.
Business sector. This improvement is also what the business sector is expecting. Despite the slowing in the consumer economy, business confidence and investment hit new post-pandemic highs last month and remain above pre-pandemic levels.
With the improvements in hiring, layoffs, and spending, the consumer economy should improve further. As the stress lifts, with the existing and prospective fiscal stimulus package, the medical improvements, and the acceleration in vaccine deployment, the economy now looks like it will keep growing as we are seeing consumer confidence and spending bounce back, as we saw after previous waves. While the risks are real, we now see most of the economic risks are moving behind us as well.
The Markets: Hold Gains on Vaccine and Stimulus News
Markets continued to move toward all-time highs again. We did see some volatility, largely attributed to turbulence within the financial markets themselves. But this, too, represents progress, as the pandemic is no longer the determinative factor. Despite that turbulence, between the ongoing medical and economic improvements, markets continue to expect a much better 2021 and that has supported prices. Fourth-quarter earnings are coming in well ahead of expectations, and analysts are now adjusting their 2021 earnings estimates upwards, which suggests this positive trend might continue as well.
While risks remain, the data says we are moving beyond the third wave of the pandemic and that medical risks may be dropping. Similarly, while the economic damage has been real, with economies reopening and the federal stimulus supporting the most vulnerable parts of the economy, we are moving past the worst of it. The most likely case for the next couple of weeks appears to be continued improvement of the medical news, as well as economic improvement as reopenings take effect. Markets will likely keep bouncing around on new developments, so expect more volatility in the short term.
In the longer term, the good news is that vaccines are now rolling out increasingly quickly. In a couple of months, we should be approaching the end of the pandemic, when the economy can normalize and start to really grow again. Despite the real risks that still remain, we are making progress and at an accelerating rate.
Weller Group is located at 6206 Slocum Road, Ontario, NY 14519 and can be reached at 315-524-8000. Securities and Advisory Services offered through Commonwealth Financial Network®, Member FINRA/SIPC, a Registered Investment Adviser. Fixed insurance products and services serviced through Weller Group LLC and KAFL, Inc. are separate and unrelated to Commonwealth.
Authored by Brad McMillan, CFA®, CAIA, MAI, managing principal, chief investment officer, at Commonwealth Financial Network®.
© 2021 Commonwealth Financial Network®